PT94105A - Processo para a preparacao de (quinolin-2-il-metoxi)fenil-acil-sulfonamidas e -cianamidas substituidas uteis como madicamentos - Google Patents

Processo para a preparacao de (quinolin-2-il-metoxi)fenil-acil-sulfonamidas e -cianamidas substituidas uteis como madicamentos

Info

Publication number
PT94105A
PT94105A PT94105A PT9410590A PT94105A PT 94105 A PT94105 A PT 94105A PT 94105 A PT94105 A PT 94105A PT 9410590 A PT9410590 A PT 9410590A PT 94105 A PT94105 A PT 94105A
Authority
PT
Portugal
Prior art keywords
quinolin
ylmethoxy
cianamides
methoxy
phenyl
Prior art date
Application number
PT94105A
Other languages
English (en)
Other versions
PT94105B (pt
Inventor
Siegfried Raddatz
Romanis Fruchtmann
Christian Kohlsdorfer
Reiner Muller-Peddinghaus
Pia Theisen-Popp
Klaus-Helmut Mohrs
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PT94105A publication Critical patent/PT94105A/pt
Publication of PT94105B publication Critical patent/PT94105B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D215/14—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
PT94105A 1989-05-23 1990-05-21 Processo para a preparacao de (quinolin-2-il-metoxi)fenil-acil-sulfonamidas e -cianamidas substituidas uteis como madicamentos PT94105B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3916663A DE3916663A1 (de) 1989-05-23 1989-05-23 Substituierte (chinolin-2-yl-methoxy)phenyl-acyl-sulfonamide und -cyanamide, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
SG12695A SG12695G (en) 1989-05-23 1995-01-26 Substituted (quinoline-2-yl-methoxy) phenyl-acyl-sulphonamides and cyanamides process for their preparation and their use in medicines

Publications (2)

Publication Number Publication Date
PT94105A true PT94105A (pt) 1991-01-08
PT94105B PT94105B (pt) 1996-11-29

Family

ID=25881158

Family Applications (1)

Application Number Title Priority Date Filing Date
PT94105A PT94105B (pt) 1989-05-23 1990-05-21 Processo para a preparacao de (quinolin-2-il-metoxi)fenil-acil-sulfonamidas e -cianamidas substituidas uteis como madicamentos

Country Status (18)

Country Link
US (1) US5091392A (pt)
EP (1) EP0399291B1 (pt)
JP (1) JP3004678B2 (pt)
KR (1) KR100210214B1 (pt)
AT (1) ATE108777T1 (pt)
AU (1) AU627579B2 (pt)
CA (1) CA2017135C (pt)
DD (1) DD297961A5 (pt)
DE (2) DE3916663A1 (pt)
DK (1) DK0399291T3 (pt)
ES (1) ES2056294T3 (pt)
HK (1) HK33395A (pt)
HU (1) HU215833B (pt)
IE (1) IE63593B1 (pt)
IL (1) IL94465A (pt)
PT (1) PT94105B (pt)
SG (1) SG12695G (pt)
ZA (1) ZA903939B (pt)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5304563A (en) * 1991-02-22 1994-04-19 Bayer Aktiengesellschaft 2-substituted quinolines, and their use in medicaments
DE4139751A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Thiazolyl substituierte chinolylmethoxyphenylessigsaeurederivate
DE4226649A1 (de) * 1992-08-12 1994-02-17 Bayer Ag Neue isobutylsubstituierte Methansulfonyl-chinolylmethoxyphenyl-cycloalkylessigsäureaminole
DE4105551A1 (de) * 1991-02-22 1992-08-27 Bayer Ag 2-substituierte chinoline, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE4112533A1 (de) * 1991-04-17 1992-10-22 Bayer Ag Verfahren zur herstellung von enantiomerenreinen substituierten (chinolin-2-yl-methoxy)phenyl-essigsaeuren
DE4125270A1 (de) * 1991-07-31 1993-02-04 Bayer Ag Chinolin-2-yl-methoxybenzylhydroxyharnstoffe
DE4129742A1 (de) * 1991-09-06 1993-03-11 Bayer Ag Heterocyclisch substituierte chinolylmethoxy-phenylacetamide
US5391555A (en) * 1991-11-12 1995-02-21 Miles Inc. Methods for treating inflammatory bowel disease with leukotriene synthesis inhibitors
DE4139749A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenyl-essigsaeureamide
DE4139750A1 (de) * 1991-12-03 1993-06-09 Bayer Ag, 5090 Leverkusen, De Chinolylmethoxyphenylessigsaeure-acylamide und -harnstoffe
CA2092152A1 (en) * 1992-03-23 1993-09-24 Azuma Igarashi Phenoxyacetic acid compounds and medical preparations containing them
DE4215213A1 (de) * 1992-05-09 1993-11-11 Merck Patent Gmbh Arylacetamide
DE4226519A1 (de) * 1992-08-11 1994-02-17 Bayer Ag 3-Substituierte Chinolylmethoxy-phenylessigsäurederivate
DE4235133A1 (de) * 1992-10-19 1994-04-21 Bayer Ag Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
IL109431A (en) * 1993-05-14 2001-01-11 Warner Lambert Co Pharmaceutical compositions containing n-acyl sulfamic acid esters (or thioesters), n-acyl sulfonamides, and n-sulfonyl carbamic acid esters (or thioesters), for regulating plasma cholesterol concentration, and certain such novel compounds
US5491172A (en) * 1993-05-14 1996-02-13 Warner-Lambert Company N-acyl sulfamic acid esters (or thioesters), N-acyl sulfonamides, and N-sulfonyl carbamic acid esters (or thioesters) as hypercholesterolemic agents
DE4443892A1 (de) * 1994-12-09 1996-06-13 Bayer Ag 4-(Chinolin-2-yl-methoxy)-phenyl-essigsäurederivate
DE4443891A1 (de) 1994-12-09 1996-06-13 Bayer Ag Heterocyclisch substituierte Oxy-phenyl-(phenyl)glycinolamide
GB2356139A (en) * 1999-11-15 2001-05-16 Bayer Ag Use of substituted (quinolin-2-yl-methoxy)phenyl-acyl-sulphonamides and cyanamides for the treatment of diseases
PE20050676A1 (es) 2003-12-12 2005-11-02 Wyeth Corp Quinolinas referidas a enfermedades cardiovasculares
EP2636407A3 (en) * 2007-03-30 2013-11-06 Tioga Pharmaceuticals, Inc. Kappa-opiate agonists for the treatment of diarrhea-predominant and alternating irritable bowel syndrome

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3682160D1 (de) * 1985-10-16 1991-11-28 Merck Frosst Canada Inc 2-substituierte chinoline.
EP0309541B1 (en) * 1987-03-18 1992-01-02 American Home Products Corporation Sulfonylcarboxamides
DE3927369A1 (de) * 1989-08-19 1991-02-21 Bayer Ag Substituierte n-(chinolin-2-yl-methoxy)benzyl-sulfonyl-harnstoffe
DE3927931A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Disubstituierte (chinolin-2-yl-methoxy)phenylessigsaeure-derivate
DE3927930A1 (de) * 1989-08-24 1991-02-28 Bayer Ag Cyclisch substituierte (chinolin-2-yl-methoxy)phenyl-essig-saeure-derivate

Also Published As

Publication number Publication date
JP3004678B2 (ja) 2000-01-31
KR100210214B1 (ko) 1999-07-15
AU5586790A (en) 1990-11-29
JPH035459A (ja) 1991-01-11
CA2017135A1 (en) 1990-11-23
DK0399291T3 (da) 1994-11-14
PT94105B (pt) 1996-11-29
IL94465A (en) 1994-07-31
DD297961A5 (de) 1992-01-30
HUT54655A (en) 1991-03-28
ZA903939B (en) 1991-03-27
EP0399291A3 (de) 1991-03-06
DE59006474D1 (de) 1994-08-25
CA2017135C (en) 2001-07-10
IL94465A0 (en) 1991-03-10
IE901851L (en) 1990-11-23
US5091392A (en) 1992-02-25
HU903132D0 (en) 1990-10-28
HK33395A (en) 1995-03-17
EP0399291A2 (de) 1990-11-28
EP0399291B1 (de) 1994-07-20
ES2056294T3 (es) 1994-10-01
AU627579B2 (en) 1992-08-27
SG12695G (en) 1995-06-16
ATE108777T1 (de) 1994-08-15
DE3916663A1 (de) 1990-11-29
IE63593B1 (en) 1995-05-17
KR900018037A (ko) 1990-12-20
HU215833B (hu) 2001-06-28

Similar Documents

Publication Publication Date Title
HUT54655A (en) Process for producing substituted (quinolin-2-ylmethoxy)-phenylacyl sulfonamides and cyanamides, as well as pharmaceutical compositions comprising same
ATE61357T1 (de) Substituierte phenylsulfonamide.
BR8805440A (pt) Processo para a fabricacao de 1,1,1-trifluorodicloroetano e/ou 1,1,1,2-tetrafluorocloroetano por fluoracao de um tetrahaloetileno
BR7803712A (pt) Sutura sintetica de multifilamento,e processo para melhorar as caracteristicas de amarracao de uma sutura de multifilamento
PT84144B (pt) Processo para a preparacao de sulfonamidas heterociclicas uteis como agente antialergicos e antitromboticos
DK0414019T3 (da) Substituerede N-(quinolin-2-yl-methoxy)benzyl-sulfonylurinstoffer
BR8005621A (pt) Processo de fabricacao e aparelho para utilizacao na montagem de batentes,vigas e similares
BR7904386A (pt) Processo para a producao de um latex de borracha auto-reticulavel,livre de emulsionante e latex de borracha
BR7900376A (pt) Processo para a producao de um catalisador,catalisador assim obtido,sua aplicacao,e processo para a producao de uma poliolefina
IT8025261A0 (it) Procedimento per la produzione di teatrafluoruro di zolfo.
BR7802700A (pt) Processo para calcinacao de calcareo ou cal hidratada
BR7904618A (pt) Processo para a preparacao de uma prancha de apara de madeira e prancha de apara de madeira obtida por ligacao entre si
BR8804931A (pt) Processo para a producao de uma tetra-hidro-1,3,5-tiadiazin-4-ona,e,composicao inseticida
IT1122745B (it) Procedimento per la produzione di diciclopentilen parentesi quadra aperta 2,2'-bis(4-alchil-6-t-butilfenoli)parentesi quadra chiusa
ES2038242T3 (es) Nuevos compuestos de tiofeno y su preparacion.
IT1123138B (it) Processo per la preparazione di 2,2'-bis(fenol 4-sostituito)solfuri
DE3888543D1 (de) Zusammensetzungen zur herstellung von gasdurchlässigen kontaktlinsen.
NO823550L (no) Produkt anvendtbart som dyrefor eller gjoedning, samt fremgangsmaate for dets fremstilling
PT84011B (pt) Processo para a preparacao de novos analogos de compostos polipeptidicos e hipocalcificantes e de composicoes farmaceuticas que os contem
IT1097538B (it) Processo per la preparazione del 2,6-dimetil-4-3(3-nitrofenil)-3-metossicarbonil-1,4-didropiridin-5-carbossilati di 2(n-benzil-n-metilammino)
MX9304608A (es) Nuevas (n-metanosulfonil)-quinolilmetoxifenil-cicoalquilacetamidas sustituidas por isobutilo, procedimiento para su preparacion y medicamentos que las contienen.
PT96179A (pt) Processo para a preparacao de 2-acilamino-9-acil-6-halopurinas
BR8905403A (pt) Processo para sintetizar n,n'-ditiobis (sulfonamidas)
FI864146A0 (fi) Mitogena peptider.
IT7820684A0 (it) Processo per la preparazione di 6 isobornil 3,4 xilenolo.

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19960829

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19980228

NF3A Restitutio in integrum

Effective date: 19980722

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 20040229